SIEMENS HEALTHINEERS AG (SHL.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SHL - DE000SHL1006 - Common Stock
44.5 EUR
-0.24 (-0.54%)
Overall SHL gets a fundamental rating of 5 out of 10. We evaluated SHL against 65 industry peers in the Health Care Equipment & Supplies industry. There are concerns on the financial health of SHL while its profitability can be described as average. SHL has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SHL was profitable.
SHL had a positive operating cash flow in the past year.
In the past 5 years SHL has always been profitable.
In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.83%, SHL is in the better half of the industry, outperforming 63.08% of the companies in the same industry.
SHL has a better Return On Equity (11.88%) than 67.69% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.65%, SHL is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 9.71%.
The 3 year average ROIC (6.28%) for SHL is below the current ROIC(7.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROIC | 7.65% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
The Profit Margin of SHL (9.17%) is better than 64.62% of its industry peers.
SHL's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 13.53%, SHL is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
In the last couple of years the Operating Margin of SHL has remained more or less at the same level.
SHL has a worse Gross Margin (38.63%) than 80.00% of its industry peers.
SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SHL is creating some value.
The number of shares outstanding for SHL has been reduced compared to 1 year ago.
The number of shares outstanding for SHL has been increased compared to 5 years ago.
Compared to 1 year ago, SHL has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.05 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
SHL has a Altman-Z score (2.05) which is comparable to the rest of the industry.
SHL has a debt to FCF ratio of 5.45. This is a neutral value as SHL would need 5.45 years to pay back of all of its debts.
With a Debt to FCF ratio value of 5.45, SHL perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
A Debt/Equity ratio of 0.63 indicates that SHL is somewhat dependend on debt financing.
SHL has a Debt to Equity ratio of 0.63. This is in the lower half of the industry: SHL underperforms 69.23% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Altman-Z | 2.05 |
ROIC/WACC1.21
WACC6.3%
2.3 Liquidity
SHL has a Current Ratio of 1.11. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
SHL's Current ratio of 1.11 is on the low side compared to the rest of the industry. SHL is outperformed by 72.31% of its industry peers.
A Quick Ratio of 0.79 indicates that SHL may have some problems paying its short term obligations.
SHL's Quick ratio of 0.79 is on the low side compared to the rest of the industry. SHL is outperformed by 72.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.17% over the past year.
Measured over the past years, SHL shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.29% on average per year.
Looking at the last year, SHL shows a small growth in Revenue. The Revenue has grown by 4.53% in the last year.
The Revenue has been growing by 10.08% on average over the past years. This is quite good.
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
3.2 Future
SHL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.79% yearly.
The Revenue is expected to grow by 5.85% on average over the next years.
EPS Next Y1.78%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
EPS Next 5Y8.79%
Revenue Next Year3.08%
Revenue Next 2Y4.57%
Revenue Next 3Y5.17%
Revenue Next 5Y5.85%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 18.62, which indicates a rather expensive current valuation of SHL.
Compared to the rest of the industry, the Price/Earnings ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 83.08% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SHL to the average of the S&P500 Index (26.57), we can say SHL is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 18.29, the valuation of SHL can be described as rather expensive.
SHL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SHL is cheaper than 63.08% of the companies in the same industry.
SHL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.62 | ||
| Fwd PE | 18.29 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SHL is valued a bit cheaper than the industry average as 64.62% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SHL indicates a rather cheap valuation: SHL is cheaper than 84.62% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.5 | ||
| EV/EBITDA | 13.94 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)10.48
PEG (5Y)1.65
EPS Next 2Y6.58%
EPS Next 3Y8.95%
5. Dividend
5.1 Amount
SHL has a Yearly Dividend Yield of 2.24%.
SHL's Dividend Yield is rather good when compared to the industry average which is at 1.03. SHL pays more dividend than 81.54% of the companies in the same industry.
SHL's Dividend Yield is comparable with the S&P500 average which is at 1.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.24% |
5.2 History
The dividend of SHL has a limited annual growth rate of 4.38%.
Dividend Growth(5Y)4.38%
Div Incr Years0
Div Non Decr Years6
5.3 Sustainability
49.72% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
The dividend of SHL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.72%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
FRA:SHL (12/23/2025, 7:00:00 PM)
44.5
-0.24 (-0.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners12.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap50.20B
Revenue(TTM)23.38B
Net Income(TTM)2.14B
Analysts80
Price Target56.61 (27.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.24% |
Yearly Dividend0.95
Dividend Growth(5Y)4.38%
DP49.72%
Div Incr Years0
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.69%
Min EPS beat(2)-3.98%
Max EPS beat(2)13.36%
EPS beat(4)2
Avg EPS beat(4)3.9%
Min EPS beat(4)-3.98%
Max EPS beat(4)13.36%
EPS beat(8)5
Avg EPS beat(8)4.19%
EPS beat(12)7
Avg EPS beat(12)2.71%
EPS beat(16)10
Avg EPS beat(16)2.88%
Revenue beat(2)0
Avg Revenue beat(2)-2.43%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)-0.77%
Revenue beat(4)2
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)1.29%
Revenue beat(8)2
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-0.98%
Revenue beat(16)7
Avg Revenue beat(16)-0.37%
PT rev (1m)-6.61%
PT rev (3m)-8.52%
EPS NQ rev (1m)1.03%
EPS NQ rev (3m)-8.32%
EPS NY rev (1m)-4.69%
EPS NY rev (3m)-7.09%
Revenue NQ rev (1m)0.45%
Revenue NQ rev (3m)1.66%
Revenue NY rev (1m)-1.1%
Revenue NY rev (3m)-1.45%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.62 | ||
| Fwd PE | 18.29 | ||
| P/S | 2.15 | ||
| P/FCF | 18.5 | ||
| P/OCF | 14.21 | ||
| P/B | 2.78 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.94 |
EPS(TTM)2.39
EY5.37%
EPS(NY)2.43
Fwd EY5.47%
FCF(TTM)2.41
FCFY5.41%
OCF(TTM)3.13
OCFY7.04%
SpS20.72
BVpS15.99
TBVpS-4.95
PEG (NY)10.48
PEG (5Y)1.65
Graham Number29.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.83% | ||
| ROE | 11.88% | ||
| ROCE | 9.97% | ||
| ROIC | 7.65% | ||
| ROICexc | 8.31% | ||
| ROICexgc | 43.54% | ||
| OM | 13.53% | ||
| PM (TTM) | 9.17% | ||
| GM | 38.63% | ||
| FCFM | 11.61% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.75%
ROICexc(5y)6.62%
ROICexgc(3y)33.94%
ROICexgc(5y)34.43%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y11.98%
ROICexgc growth 5Y11.06%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-1.26%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score8
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 5.45 | ||
| Debt/EBITDA | 2.54 | ||
| Cap/Depr | 63.12% | ||
| Cap/Sales | 3.5% | ||
| Interest Coverage | 7.04 | ||
| Cash Conversion | 79.23% | ||
| Profit Quality | 126.59% | ||
| Current Ratio | 1.11 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 2.05 |
F-Score8
WACC6.3%
ROIC/WACC1.21
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)7.17%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%1.49%
EPS Next Y1.78%
EPS Next 2Y6.58%
EPS Next 3Y8.95%
EPS Next 5Y8.79%
Revenue 1Y (TTM)4.53%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-0.11%
Revenue Next Year3.08%
Revenue Next 2Y4.57%
Revenue Next 3Y5.17%
Revenue Next 5Y5.85%
EBIT growth 1Y12.53%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year35.66%
EBIT Next 3Y17.7%
EBIT Next 5Y14.23%
FCF growth 1Y27.42%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y24.98%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
What is the valuation status of SIEMENS HEALTHINEERS AG (SHL.DE) stock?
ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
Can you provide the profitability details for SIEMENS HEALTHINEERS AG?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for SHL stock?
The Price/Earnings (PE) ratio for SIEMENS HEALTHINEERS AG (SHL.DE) is 18.62 and the Price/Book (PB) ratio is 2.78.
Can you provide the dividend sustainability for SHL stock?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 49.72%.